Cargando…
PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010115/ https://www.ncbi.nlm.nih.gov/pubmed/33785733 http://dx.doi.org/10.1038/s41392-021-00522-6 |
_version_ | 1783672994714877952 |
---|---|
author | Xie, Qin Chi, Shuaishuai Fang, Yanfen Sun, Yiming Meng, Linghua Ding, Jian Chen, Yi |
author_facet | Xie, Qin Chi, Shuaishuai Fang, Yanfen Sun, Yiming Meng, Linghua Ding, Jian Chen, Yi |
author_sort | Xie, Qin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8010115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80101152021-04-16 PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma Xie, Qin Chi, Shuaishuai Fang, Yanfen Sun, Yiming Meng, Linghua Ding, Jian Chen, Yi Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-03-31 /pmc/articles/PMC8010115/ /pubmed/33785733 http://dx.doi.org/10.1038/s41392-021-00522-6 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Xie, Qin Chi, Shuaishuai Fang, Yanfen Sun, Yiming Meng, Linghua Ding, Jian Chen, Yi PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title | PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title_full | PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title_fullStr | PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title_full_unstemmed | PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title_short | PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma |
title_sort | pi3kα inhibitor impairs akt phosphorylation and synergizes with novel angiogenesis inhibitor al3810 in human hepatocellular carcinoma |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010115/ https://www.ncbi.nlm.nih.gov/pubmed/33785733 http://dx.doi.org/10.1038/s41392-021-00522-6 |
work_keys_str_mv | AT xieqin pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT chishuaishuai pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT fangyanfen pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT sunyiming pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT menglinghua pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT dingjian pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma AT chenyi pi3kainhibitorimpairsaktphosphorylationandsynergizeswithnovelangiogenesisinhibitoral3810inhumanhepatocellularcarcinoma |